TransMedics Group Inc (TMDX)

Quick ratio

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash	US$ in thousands	330,094	362,751	350,217	394,812	427,110	582,210	195,375	201,182	204,462	30,386	17,897	25,580	22,495	25,314	26,727	24,581	21,397	51,152	24,738	20,092
Short-term investments	US$ in thousands	—	—	—	—	—	—	—	—	38	27,714	54,103	66,920	80,405	86,886	91,373	101,019	111,303	88,248	47,862	60,608
Receivables	US$ in thousands	90,128	81,158	81,942	63,576	60,654	47,524	38,620	27,611	22,035	12,979	11,724	5,934	4,150	6,271	7,395	6,864	6,141	4,431	6,133	6,559
Total current liabilities	US$ in thousands	60,048	54,329	50,223	54,934	49,101	32,017	28,635	23,661	20,689	22,741	20,256	23,238	15,923	15,079	11,757	11,879	13,624	13,818	15,039	16,115
Quick ratio		7.00	8.17	8.60	8.34	9.93	19.67	8.17	9.67	10.95	3.13	4.13	4.24	6.72	7.86	10.67	11.15	10.19	10.41	5.24	5.41

September 30, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($330,094K + $—K + $90,128K) ÷ $60,048K
= 7.00

The quick ratio of TransMedics Group Inc has shown fluctuations over the past eight quarters, ranging from 3.13 to 19.67. The quick ratio measures the company's ability to meet its short-term obligations with its most liquid assets, excluding inventory. A higher quick ratio indicates a stronger liquidity position as the company has an increased ability to cover its current liabilities without relying on selling inventory.

In the most recent quarter, the quick ratio stood at 7.00, indicating that TransMedics has $7.00 of liquid assets available to cover each $1.00 of current liabilities. This suggests that the company has a healthy liquidity position and is well-equipped to meet its short-term financial obligations.

Overall, the varying levels of the quick ratio over the quarters may reflect changes in the company's cash and cash equivalents, marketable securities, and accounts receivable. Investors and analysts should continue to monitor the trend of the quick ratio to assess TransMedics Group Inc's liquidity position and financial health.